Karen E. Pollok was named co-leader of the Experimental and Developmental Therapeutics research program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. She joins Mat Opyrchal as co-leader.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center began a public education campaign that focuses on cancer early detection and prevention.
In a first-in-human clinical trial for patients with relapsed multiple myeloma, led by researchers at Indiana University Melvin and Bren Simon Comprehensive Cancer Center, patients treated with higher doses of the immunotherapy called REGN5459 resulted in a 90.5% overall response rate.
While trying to understand what initiates breast cells to become cancerous, researchers at the Vera Bradley Foundation Center for Breast Cancer Research at Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a new target for breast cancer treatment.
Gifts totaling $3 million will create an endowed chair in cancer informatics at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Michele Coté was named director of the Susan G. Komen Tissue Bank, the world’s only healthy breast tissue bank, at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
More than $2 million was raised for research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Shelley Johns was named the Walther Scholar in Psycho-Oncology at Indiana University School of Medicine.
A gift commitment of $12.5 million to Indiana University School of Medicine from the Vera Bradley Foundation for Breast Cancer will support research in immunotherapy for triple negative breast cancer.
The National Comprehensive Cancer Network named Indiana University Melvin and Bren Simon Comprehensive Cancer Center as its 32nd Member Institution.
